Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 5,048 | 5,664 | 5,062 | 4,026 | 5,226 |
| Operating Income | -5,048 | -5,664 | -5,062 | -4,026 | -5,226 |
| Interest Expense | 41 | 52 | 72 | 175 | 232 |
| Other Income | -82 | -41 | 75 | 56 | 388 |
| Pre-tax Income | -5,171 | -5,757 | -5,059 | -4,145 | -5,070 |
| Income Tax | 10 | 4 | 3 | 3 | -1 |
| Net Income Continuous | -5,181 | -5,761 | -5,062 | -4,148 | -5,069 |
| Minority Interests | -32 | -46 | -76 | -51 | -15 |
| Net Income | $-5,149 | $-5,715 | $-4,986 | $-4,097 | $-5,054 |
| EPS Basic Total Ops | -2.21 | -1.99 | -2.16 | 13.22 | -7.75 |
| EPS Basic Continuous Ops | -1.06 | -2.00 | -2.24 | 11.86 | -7.77 |
| EPS Diluted Total Ops | -2.21 | -1.99 | -2.16 | 13.22 | -7.75 |
| EPS Diluted Continuous Ops | -1.06 | -2.00 | -2.24 | 11.86 | -7.77 |
| EPS Diluted Before Non-Recurring Items | -2.21 | -1.99 | -2.16 | N/A | -7.80 |
| EBITDA(a) | $-4,621 | $-5,257 | $-4,668 | $-3,629 | $-4,827 |